BlackRock Group LTD - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 99 filers reported holding HERON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$164,000
-16.3%
12,582
+10.9%
0.00%
Q3 2016$196,000
+0.5%
11,345
+4.9%
0.00%
Q2 2016$195,000
+3.7%
10,816
+9.0%
0.00%
Q1 2016$188,000
+93.8%
9,919
+174.2%
0.00%
Q4 2015$97,000
-73.5%
3,618
-75.9%
0.00%
Q3 2015$366,00015,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders